Communiqués de presse Archive - Page 13 of 19 - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes

OSE Immunotherapeutics and ARCAGY – GINECO Announce Initiation of a Randomized Phase 2 Clinical Trial

OSE Immunotherapeutics to Present New Data at AACR 2021

OSE Immunotherapeutics Presentation at H.C. Wainwright Global Life Sciences Conference

OSE Immunotherapeutics Announces Granting of First European Patent Protecting OSE-127

OSE Immunotherapeutics Enters a Loan Agreement of up to €25 Million with the European Investment Bank

OSE Immunotherapeutics Expands its Collaboration with MAbSilico

INCREASE IN RESOURCES DEVOTED TO THE LIQUIDITY CONTRACT OSE IMMUNOTHERAPEUTICS

OSE Immunotherapeutics Receives €1.3 Million Milestone Payment from Bpifrance for OSE-127/S95011

OSE Immunotherapeutics Presentation at H.C. Wainwright BIOCONNECT 2021

OSE Immunotherapeutics Announces Enrolment of First Patient with Ulcerative Colitis in Phase 2

Précédent
1
…
10
11
12
13
14
15
16
…
19
Suivant